These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3074984)

  • 1. [Mucormycosis in a hemodialysis patient with iron overload].
    Arimura Y; Nakabayashi K; Kitamoto K; Nagasawa T; Tanaka U; Nakamura W; Fujita C; Takimoto M
    Nihon Naika Gakkai Zasshi; 1988 Dec; 77(12):1884-7. PubMed ID: 3074984
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal mucormycosis in a hemodialysis patient treated with desferrioxamine.
    Kaneko T; Abe F; Ito M; Hotchi M; Yamada K; Okada Y
    Acta Pathol Jpn; 1991 Jul; 41(7):561-6. PubMed ID: 1755321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucormycosis--a new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload?
    Goodill JJ; Abuelo JG
    N Engl J Med; 1987 Jul; 317(1):54. PubMed ID: 3587314
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature.
    Boelaert JR; van Roost GF; Vergauwe PL; Verbanck JJ; de Vroey C; Segaert MF
    Clin Nephrol; 1988 May; 29(5):261-6. PubMed ID: 3293856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case report of rhinocerebral mucormycosis in hemodialysis patient receiving deferoxamine].
    Arizono K; Fukui H; Miura H; Hayano K; Otsuka Y; Tajiri M
    Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):99-103. PubMed ID: 2747004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous mucormycosis with a Mucor species: is iron overload a factor?
    MacDonald ML; Weiss PJ; Deloach-Banta LJ; Comer SW
    Cutis; 1994 Oct; 54(4):275-8. PubMed ID: 7805414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of serious iron overload in a chronic hemodialysis patient by recombinant human erythropoietin and removal of red blood cells: confirmation by follow-up liver biopsy.
    Onoyama K; Nakamura S; Yamamoto M; Kawadoko T; Nanishi F; Komoda T; Murai K; Fujishima M
    Nephron; 1990; 56(3):325-8. PubMed ID: 2077417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry.
    Boelaert JR; Fenves AZ; Coburn JW
    Am J Kidney Dis; 1991 Dec; 18(6):660-7. PubMed ID: 1962650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyria cutanea tarda, hepatitis C infection, and iron overload in a patient on hemodialysis.
    Albitar S; Bourgeon B; Chuet C
    Am J Med; 1999 Feb; 106(2):266-7. PubMed ID: 10230760
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant human erythropoietin treatment reverses hepatic iron overload in hemodialysis patients.
    Berland Y; Baz M; Di Stefano D; Merzouk T; Bartoli JM; Dussol B; Kasbarian M
    Nephrol Dial Transplant; 1992; 7(4):366-7. PubMed ID: 1317533
    [No Abstract]   [Full Text] [Related]  

  • 11. Dialysis associated mucormycosis and desferrioxamine treatment: a case report with review of the role of oxygen radicals.
    Seeverens HJ; Tijhuis GJ; Ruijs GJ; Kazzaz BA; Kauffmann RH
    Neth J Med; 1992 Dec; 41(5-6):275-9. PubMed ID: 1494406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic mucormycosis in dialysis: computed tomography picture and histologic lesions].
    Mariano F; Rossano C; Goia F; Cottino R; Dogliani N; Cavalli PL
    Minerva Urol Nefrol; 1996 Mar; 48(1):51-4. PubMed ID: 8848770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of an oral iron chelator, deferasirox, in hemodialysis patients with iron overload.
    Chen CH; Shu KH; Yang Y
    Hematology; 2015 Jun; 20(5):304-10. PubMed ID: 25200910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac mucormycosis. A report of five patients and review of 14 previously reported cases.
    Virmani R; Connor DH; McAllister HA
    Am J Clin Pathol; 1982 Jul; 78(1):42-7. PubMed ID: 7102606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-linked iron overload and myopathy in maintenance hemodialysis patients.
    Bregman H; Gelfand MC; Winchester JF; Manz HJ; Knepshield JH
    Trans Am Soc Artif Intern Organs; 1980; 26():366-8. PubMed ID: 7245514
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial mucormycosis with emboli in a hemodialysis patient.
    Iqbal SM; Scheer RL
    Am J Kidney Dis; 1986 Dec; 8(6):455-8. PubMed ID: 3812477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhinocerebral mucormycosis in haemodialysis patients treated with desferrioxamine: possible role of recent surgery as an additional risk factor.
    Wens R; Devriendt J; Collart F; Dratwa M; Bisschop P; Telerman-Toppet N; Douat N
    Nephrol Dial Transplant; 1991; 6(9):656-8. PubMed ID: 1745390
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of arterial thrombus of Mucorales hyphae during deferoxamine therapy in a patient with aplastic anemia in transformation to myelodysplastic syndrome].
    Miyata Y; Kajiguchi T; Saito M; Takeyama H
    Rinsho Ketsueki; 2000 Feb; 41(2):129-34. PubMed ID: 10723242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine.
    Windus DW; Stokes TJ; Julian BA; Fenves AZ
    Ann Intern Med; 1987 Nov; 107(5):678-80. PubMed ID: 3662280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st Century.
    Rostoker G; Vaziri ND; Fishbane S
    Drugs; 2016 May; 76(7):741-57. PubMed ID: 27091216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.